We thank 50+ health systems, representing 1,200+ hospitals across the US, for joining Civica Rx to help ensure quality medicines are accessible and affordable to everyone. These include:
Experts testifying during the recent Senate Hearing cited Civica’s mission and efforts to diversify the supply chain and ensure more generic medications are made in the U.S. Civica Rx was mentioned in expert testimony during a recent Senate Small Business and Entrepreneurship Committee, chaired by Senator Marco Rubio, on the impact of the coronavirus...
Fast Company lists Civica as one of The World's 50 Most Innovative Companies for manufacturing generic drugs at lower prices to combat shortages and rising healthcare costs. Modern Healthcare names Martin VanTrieste, President and CEO of Civica Rx, as one of The 100 Most Influential People in Healthcare. “This recognition is a reflection of everything the...
The purpose of this letter is to share Civica's recommendation to close loopholes that lead to unreasonable price increases for decades-old drugs as a result of periods of exclusivity granted by the FDA for former Drug Efficacy Study Implementation (DESI) drugs. ...
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.